Deliver Your News to the World

CybeRelease: (OTC: HSPO) Announces Exclusive Agreement with Schering-Plough


(CybeRelease, June 22, 2007) - HealthSport, Inc. (“HealthSport” or the “Company”) (OTC BB: HSPO) through its wholly owned subsidiary InnoZen, Inc. (“InnoZen”) completed, by receipt of a $150,000 prepayment, an exclusive marketing and distribution agreement with Schering Plough, S.A. de C.V. of Xochimilco, Mexico (“Schering”), a subsidiary of Schering-Plough Corporation, for InnoZen’s Suppress Cough strip products. The agreement provides for the exclusive supply by InnoZen of both Suppress-Herbal and Suppress-Dextromethorphan to Schering and covers 35 Central, South American and Caribbean countries. Prior to marketing the product, Schering and InnoZen will work together to obtain a health registration for the products in Mexico. In addition, InnoZen has agreed to develop new edible filmstrip formulations and finished products for Schering Plough Latin America.

CybeRelease Gainers are TBS International Limited (Nasdaq: TBSI), Liquidity Services, Inc. (Nasdaq: LQDT), China TechFaith Wireless Communication Technology Limited (Nasdaq: CNTF), Optium Corporation (Nasdaq: OPTM), Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), Maxwell Technologies, Inc. (Nasdaq: MXWL) and LookSmart, Ltd. (Nasdaq: LOOK).

CybeRelease Decliners are Genomic Health, Inc. (Nasdaq: GHDX), Convera Corporation (Nasdaq: CNVR), Microvision, Inc. (Nasdaq: MVISW), Neurogen Corporation (Nasdaq: NRGN), Regeneration Technologies, Inc. (Nasdaq: RTIX) and Inspire Pharmaceuticals, Inc. (Nasdaq: ISPH).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.